|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 29.39 USD | +1.10% |
|
+4.70% | -40.02% |
| 10-09 | Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer | MT |
| 10-05 | Harrow Completes Acquisition of Tyrvaya Nasal Spray From Viatris | MT |
| Market Cap | 1.1B 988M 912M 827M 1.54B 105B 1.56B 10.91B 4.35B 54.9B 4.13B 4.05B 174B | P/E 2026 * |
-274x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.1B 988M 912M 827M 1.54B 105B 1.56B 10.91B 4.35B 54.9B 4.13B 4.05B 174B | EV / Sales 2026 * |
3.15x | EV / Sales 2027 * | 2.05x |
| Free-Float |
84.62% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HROW | Delayed | |
CBOE
| HROW | Real-time | |
|
Deutsche Boerse AG
| 3IP | Delayed |
Last Transcript: Harrow, Inc.
| 1 day | +1.10% | ||
| 1 week | +4.70% | ||
| Current month | -4.58% | ||
| 1 month | -11.13% | ||
| 3 months | -21.54% | ||
| 6 months | -29.03% | ||
| Current year | -40.02% |
| 1 week | 27.14 |  | 29.74 |
| 1 month | 26.96 | | 31.86 |
| Current year | 26.96 | | 54.85 |
| 1 year | 26.96 | | 54.85 |
| 3 years | 7.6 | | 59.23 |
| 5 years | 5.4 | | 59.23 |
| 10 years | 1.35 | | 59.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 53 | 16/12/2011 |
Andrew Boll
PSD | President | 43 | 20/08/2025 |
Brett Burrell
CMP | Compliance Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Baum
CHM | Chairman | 53 | 18/08/2021 |
Perry Sternberg
BRD | Director/Board Member | 57 | 30/03/2022 |
Adrienne Graves
BRD | Director/Board Member | 71 | 25/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/26 | Exercice | Chief Technology Officer | 33,750 | 0.0905% | ||
| 18/05/26 | Buy | Director | 1,000 | 0.0027% | ||
| 18/05/26 | Buy | Director | 1,000 | 0.0027% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | +4.70% | -23.14% | +114.37% | 1.09B | |
| +0.50% | +0.36% | +55.89% | +129.96% | 1,143B | |
| +0.86% | +4.50% | +42.43% | +86.15% | 647B | |
| -0.14% | -1.07% | +25.42% | +105.85% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -4.97% | +60.15% | +37.06% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | |
| +0.87% | +2.94% | +55.18% | +72.74% | 242B | |
| +0.08% | +1.72% | +32.15% | +107.78% | 197B | |
| Average | +0.40% | +1.12% | +32.42% | +80.20% | 402.86B | |
| Weighted average by Cap. | +0.46% | +0.71% | +42.61% | +89.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 350M 314M 290M 263M 490M 33.34B 497M 3.47B 1.38B 17.45B 1.31B 1.29B 55.25B | 536M 481M 444M 403M 750M 51.06B 761M 5.31B 2.12B 26.73B 2.01B 1.97B 84.63B |
| Net income | -3.92M -3.52M -3.25M -2.94M -5.49M -373M -5.56M -38.83M -15.47M -195M -14.71M -14.4M -619M | 89.19M 79.96M 73.84M 66.94M 125M 8.49B 127M 883M 352M 4.44B 335M 328M 14.07B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | US$29.39 | +1.10% | 326,165 |
| 27/10/26 | US$29.07 | +0.41% | 635,445 |
| 26/10/26 | US$28.95 | +1.79% | 499,149 |
| 23/10/26 | US$28.44 | +1.03% | 854,706 |
| 22/10/26 | US$28.15 | -0.32% | 440,124 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HROW Stock
Select your edition
All financial news and data tailored to specific country editions
